US2019023731A1PendingUtilityA1

Convergent processes for preparing macrolide antibacterial agents

59
Assignee: CEMPRA PHARMACEUTICALS INCPriority: Mar 15, 2013Filed: Feb 20, 2018Published: Jan 24, 2019
Est. expiryMar 15, 2033(~6.7 yrs left)· nominal 20-yr term from priority
C07H 17/08
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention described herein relates to processes for preparing ketolide antibacterial agents. In particular, the invention relates to intermediates and processes for preparing ketolides that include a 1,2,3-triazole substituted side chain.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled) 
     
     
         26 . A composition comprising solithromycin that is substantially free of 
       
         
           
           
               
               
           
         
       
       wherein A-B is (CH 2 ) 4 . 
     
     
         27 . A compound of the formula: 
       
         
           
           
               
               
           
         
       
       wherein:
 A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ; 
 B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or 
 AB taken together is alkylene, alkenylene, cycloalkylene, or arylene; 
 C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; and 
 R 100  is hydrogen or a hydroxyl protecting group. 
 
     
     
         28 . The compound of  claim 27  wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted. 
     
     
         29 . The compound of  claim 27  wherein A is CH 2 . 
     
     
         30 . The compound of  claim 27  wherein B is (CH 2 ) n , and n is an integer from 2-6. 
     
     
         31 . The compound of  claim 27  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         32 . The compound of  claim 27  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         33 . The compound of  claim 32  wherein R 100  is hydrogen. 
     
     
         34 . An intermediate of the formulae 
       
         
           
           
               
               
           
         
       
       wherein:
 A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ; 
 B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or 
 AB taken together is alkylene, alkenylene, cycloalkylene, or arylene; 
 C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; or C is C P , where C P  is a protected form of C; 
 R 100  is hydrogen or a hydroxyl protecting group; and 
 N P  is NH 2  or protected amino. 
 
     
     
         35 . The intermediate of  claim 34  wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted. 
     
     
         36 . The intermediate of  claim 34  wherein A is CH 2 . 
     
     
         37 . The intermediate of  claim 34  wherein B is (CH 2 ) n , and n is an integer from 2-6. 
     
     
         38 . The intermediate of  claim 34  wherein B is (CH 2 ) n , and n is 2, 3, or 
     
     
         4 . 
     
     
         39 . The intermediate of  claim 34  wherein R 100  is acyl. 
     
     
         40 . The intermediate of  claim 34  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         41 . The intermediate of  claim 34  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         42 . The intermediate of  claim 34  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         43 . The intermediate of  claim 34  of the formula 
       
         
           
           
               
               
           
         
       
     
     
         44 . The intermediate of  claim 34  of the formula

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.